A new trading day began on Monday, with MBX Biosciences Inc (NASDAQ: MBX) stock price down -4.06% from the previous day of trading, before settling in for the closing price of $30.55. MBX’s price has ranged from $4.81 to $35.55 over the past 52 weeks.
Meanwhile, its annual earnings per share averaged 56.40%. With a float of $26.48 million, this company’s outstanding shares have now reached $44.72 million.
MBX Biosciences Inc (MBX) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of MBX Biosciences Inc is 41.02%, while institutional ownership is 68.73%. The most recent insider transaction that took place on Oct 20 ’25, was worth 272,790. In this transaction President & CEO of this company bought 20,000 shares at a rate of $13.64, taking the stock ownership to the 468,277 shares. Before that another transaction happened on Oct 17 ’25, when Company’s Director bought 20,000 for $13.25, making the entire transaction worth $264,984. This insider now owns 20,000 shares in total.
MBX Biosciences Inc (MBX) Performance Highlights and Predictions
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.47 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.72 per share during the current fiscal year.
MBX Biosciences Inc (NASDAQ: MBX) Trading Performance Indicators
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.39, a number that is poised to hit -0.67 in the next quarter and is forecasted to reach -3.12 in one year’s time.
Technical Analysis of MBX Biosciences Inc (MBX)
The latest stats from [MBX Biosciences Inc, MBX] show that its last 5-days average volume of 0.47 million was inferior to 0.66 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 31.30%.
During the past 100 days, MBX Biosciences Inc’s (MBX) raw stochastic average was set at 75.93%, which indicates a significant increase from 26.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.10 in the past 14 days, which was higher than the 1.77 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $27.39, while its 200-day Moving Average is $15.81. Now, the first resistance to watch is $30.93. This is followed by the second major resistance level at $32.54. The third major resistance level sits at $34.09. If the price goes on to break the first support level at $27.77, it is likely to go to the next support level at $26.22. Assuming the price breaks the second support level, the third support level stands at $24.61.
MBX Biosciences Inc (NASDAQ: MBX) Key Stats
With a market capitalization of 1.32 billion, the company has a total of 44,902K Shares Outstanding. Currently, annual sales are 0 K while annual income is -61,920 K. The company’s previous quarter sales were 0 K while its latest quarter income was -21,620 K.
